trending Market Intelligence /marketintelligence/en/news-insights/trending/LiR5WX5WlE92rDkGfM0E1A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

NY attorney general sues insurer over denial of hepatitis treatment coverage

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Fintech Funding Flows To Insurtech In February

NY attorney general sues insurer over denial of hepatitis treatment coverage

New York Attorney General Eric Schneiderman filed a lawsuit inNew York Supreme Court against CapitalDistrict Physicians' Health Plan Inc., alleging that the company unlawfullyrestricted coverage of treatment for chronic hepatitis C infection in violationof New York State Insurance Law and Public Health Law.

The lawsuit alleges that Capital District denied coverage forsuch treatment unless the member demonstrated advanced disease, such as moderateto severe liver scarring. Members diagnosed with early stage chronic hepatitis Cinfection must monitor their disease and wait until they develop liver scarringor other advanced disease before their treatment will be covered.

The complaint further alleges that Capital District may haverestricted coverage of hepatitis C treatment because of the potential expense, yetits plan documents never disclosed to current or potential members that it consideredcost when deciding whether treatment for a disease would be covered by the plan.By failing to disclose that cost is a consideration in making determinations asto whether and when treatment is deemed "medically necessary," and byfailing to cover treatment for hepatitis C even when it meets the plans' definitionsof "medically necessary," the lawsuit alleges, Capital District is misleadingits members about the scope of their coverage.

Ali Skinner, Capital District's director of strategic communications,said the company covers hepatitis C prescription drug treatments in a manner comparableto virtually every other health plan, and that in some cases its coverage goes further.Skinner added that coverage decisions are made based on the use of evidence-basedclinical criteria, "not upon political agendas or actions." She furthernoted that the attorney general's office has filed the initial litigation againstthe company despite an ongoing dialogue between the entire industry and the state.